ATARA BIOTHERAPEUTICS, INC. Increase (Decrease) in Accounts Payable
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Increase (Decrease) in Accounts Payable of $697.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-12
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $187.00K.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $510.00K.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$191.00K, a 108.59% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$983.00K.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2025 was -$4.24M, a 717.18% decline from fiscal 2024.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2024 was $687.00K.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2023 was -$3.13M.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2022 was -$9.21M, a 201.59% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 4 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $187.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $697.00K 10-Q · filed 2026-08-12 | $506.00K derived: sum of 3 quarters · filed 2026-08-12 | -$477.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | $510.00K 10-Q · filed 2026-05-12 | $319.00K derived: sum of 2 quarters · filed 2026-05-12 | -$664.00K derived: sum of 3 quarters · filed 2026-05-12 | -$747.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | -$191.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$1.17M derived: sum of 2 quarters · filed 2026-03-16 | -$1.26M derived: sum of 3 quarters · filed 2026-08-12 | -$4.24M 10-K · filed 2026-03-16 | |
| 2025-09-30 | -$983.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$1.07M derived: sum of 2 quarters · filed 2026-08-12 | -$4.05M 10-Q · filed 2025-11-12 | -$1.82M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | -$83.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$3.07M 10-Q · filed 2026-08-12 | -$842.00K derived: sum of 3 quarters · filed 2026-08-12 | -$3.95M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | -$2.98M 10-Q · filed 2026-05-12 | -$759.00K derived: sum of 2 quarters · filed 2026-05-12 | -$3.87M derived: sum of 3 quarters · filed 2026-05-12 | -$1.47M derived: sum of 4 quarters · filed 2026-05-12 | |
| 2024-12-31 | $2.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$886.00K derived: sum of 2 quarters · filed 2026-03-16 | $1.51M derived: sum of 3 quarters · filed 2026-03-16 | $687.00K 10-K · filed 2026-03-16 | |
| 2024-09-30 | -$3.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$711.00K derived: sum of 2 quarters · filed 2025-11-12 | -$1.54M 10-Q · filed 2025-11-12 | -$4.35M derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $1.57M 10-Q · filed 2025-08-11 | -$1.24M derived: sum of 3 quarters · filed 2025-08-11 | $1.22M derived: sum of 4 quarters · filed 2025-08-11 | |
| 2024-03-31 | -$826.00K 10-Q · filed 2025-05-15 | -$3.64M derived: sum of 2 quarters · filed 2025-05-15 | -$1.18M derived: sum of 3 quarters · filed 2025-05-15 | -$2.07M derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | -$2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$350.00K derived: sum of 2 quarters · filed 2025-03-07 | -$1.24M derived: sum of 3 quarters · filed 2025-03-07 | -$3.13M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $2.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.57M derived: sum of 2 quarters · filed 2024-11-12 | -$319.00K 10-Q · filed 2024-11-12 | -$4.77M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | -$894.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$2.78M 10-Q · filed 2024-08-12 | -$7.23M derived: sum of 3 quarters · filed 2024-08-12 | -$8.61M derived: sum of 4 quarters · filed 2024-08-12 | |
| 2023-03-31 | -$1.89M 10-Q · filed 2024-05-09 | -$6.34M derived: sum of 2 quarters · filed 2024-05-09 | -$7.71M derived: sum of 3 quarters · filed 2024-05-09 | -$6.51M derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | -$4.45M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$5.83M derived: sum of 2 quarters · filed 2024-03-28 | -$4.62M derived: sum of 3 quarters · filed 2024-03-28 | -$9.21M 10-K · filed 2024-03-28 | |
| 2022-09-30 | -$1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$172.00K derived: sum of 2 quarters · filed 2023-11-01 | -$4.76M 10-Q · filed 2023-11-01 | -$4.40M derived: sum of 4 quarters · filed 2023-11-01 | |
| 2022-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$3.38M 10-Q · filed 2023-08-08 | -$3.03M derived: sum of 3 quarters · filed 2023-08-08 | $1.33M derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | -$4.59M 10-Q · filed 2023-05-08 | -$4.23M derived: sum of 2 quarters · filed 2023-05-08 | $123.00K derived: sum of 3 quarters · filed 2023-05-08 | -$5.08M derived: sum of 4 quarters · filed 2023-05-08 | |
| 2021-12-31 | $357.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-08 | $4.71M derived: sum of 2 quarters · filed 2023-02-08 | -$488.00K derived: sum of 3 quarters · filed 2023-02-08 | $9.07M 10-K · filed 2023-02-08 | |
| 2021-09-30 | $4.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$845.00K derived: sum of 2 quarters · filed 2022-11-08 | $8.71M 10-Q · filed 2022-11-08 | $10.61M derived: sum of 4 quarters · filed 2023-02-08 | |
| 2021-06-30 | -$5.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $4.36M 10-Q · filed 2022-08-08 | $6.26M derived: sum of 3 quarters · filed 2023-02-08 | $6.47M derived: sum of 4 quarters · filed 2023-02-08 | |
| 2021-03-31 | $9.55M 10-Q · filed 2022-05-05 | $11.46M derived: sum of 2 quarters · filed 2023-02-08 | $11.67M derived: sum of 3 quarters · filed 2023-02-08 | $9.33M derived: sum of 4 quarters · filed 2023-02-08 | |
| 2020-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-08 | $2.12M derived: sum of 2 quarters · filed 2023-02-08 | -$225.00K derived: sum of 3 quarters · filed 2023-02-08 | -$815.00K 10-K · filed 2023-02-08 | |
| 2020-09-30 | $215.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$2.13M derived: sum of 2 quarters · filed 2021-11-04 | -$2.72M 10-Q · filed 2021-11-04 | -$32.00K derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | -$2.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$2.93M 10-Q · filed 2021-08-09 | -$247.00K derived: sum of 3 quarters · filed 2022-02-28 | -$1.37M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-03-31 | -$590.00K 10-Q · filed 2021-05-04 | $2.10M derived: sum of 2 quarters · filed 2022-02-28 | $974.00K derived: sum of 3 quarters · filed 2022-02-28 | $951.00K derived: sum of 4 quarters · filed 2022-02-28 | |
| 2019-12-31 | $2.69M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.56M derived: sum of 2 quarters · filed 2022-02-28 | $1.54M derived: sum of 3 quarters · filed 2022-02-28 | $4.21M 10-K · filed 2022-02-28 | |
| 2019-09-30 | -$1.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$1.15M derived: sum of 2 quarters · filed 2020-11-09 | $1.53M 10-Q · filed 2020-11-09 | -$547.00K derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | -$23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $2.65M 10-Q · filed 2020-08-05 | $575.00K derived: sum of 3 quarters · filed 2021-03-01 | $898.00K derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | $2.67M 10-Q · filed 2020-05-06 | $598.00K derived: sum of 2 quarters · filed 2021-03-01 | $921.00K derived: sum of 3 quarters · filed 2021-03-01 | $2.83M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | -$2.07M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$1.75M derived: sum of 2 quarters · filed 2021-03-01 | $161.00K derived: sum of 3 quarters · filed 2021-03-01 | -$1.96M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $323.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $2.23M derived: sum of 2 quarters · filed 2019-11-07 | $116.00K 10-Q · filed 2019-11-07 | $2.28M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | $1.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$207.00K 10-Q · filed 2019-08-08 | $1.96M derived: sum of 3 quarters · filed 2020-02-27 | $1.70M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-03-31 | -$2.12M 10-Q · filed 2019-05-09 | $45.00K derived: sum of 2 quarters · filed 2020-02-27 | -$209.00K derived: sum of 3 quarters · filed 2020-02-27 | $510.00K derived: sum of 4 quarters · filed 2020-02-27 | |
| 2017-12-31 | $2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $1.91M derived: sum of 2 quarters · filed 2020-02-27 | $2.63M derived: sum of 3 quarters · filed 2020-02-27 | $2.16M 10-K · filed 2020-02-27 | |
| 2017-09-30 | -$254.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $465.00K derived: sum of 2 quarters · filed 2018-11-06 | -$1.00K 10-Q · filed 2018-11-06 | -$2.04M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-06-30 | $719.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $253.00K 10-Q · filed 2018-08-01 | -$1.78M derived: sum of 3 quarters · filed 2019-02-26 | -$556.00K derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-03-31 | -$466.00K 10-Q · filed 2018-05-08 | -$2.50M derived: sum of 2 quarters · filed 2019-02-26 | -$1.27M derived: sum of 3 quarters · filed 2019-02-26 | $64.00K derived: sum of 4 quarters · filed 2019-02-26 | |
| 2016-12-31 | -$2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$809.00K derived: sum of 2 quarters · filed 2019-02-26 | $530.00K derived: sum of 3 quarters · filed 2019-02-26 | $981.00K 10-K · filed 2019-02-26 | |
| 2016-09-30 | $1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $2.57M derived: sum of 2 quarters · filed 2017-11-09 | $3.02M 10-Q · filed 2017-11-09 | $2.61M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-06-30 | $1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $1.79M 10-Q · filed 2017-08-07 | $1.38M derived: sum of 3 quarters · filed 2018-02-27 | $1.63M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-03-31 | $451.00K 10-Q · filed 2017-05-04 | $43.00K derived: sum of 2 quarters · filed 2018-02-27 | $294.00K derived: sum of 3 quarters · filed 2018-02-27 | $1.10M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2015-12-31 | -$408.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$157.00K derived: sum of 2 quarters · filed 2018-02-27 | $651.00K derived: sum of 3 quarters · filed 2018-02-27 | $1.00M 10-K · filed 2018-02-27 | |
| 2015-09-30 | $251.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $1.06M derived: sum of 2 quarters · filed 2016-11-04 | $1.41M 10-Q · filed 2016-11-04 | $1.29M derived: sum of 4 quarters · filed 2017-03-09 | |
| 2015-06-30 | $808.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $1.16M 10-Q · filed 2016-08-08 | $1.03M derived: sum of 3 quarters · filed 2017-03-09 | $1.03M derived: sum of 4 quarters · filed 2017-03-09 | |
| 2015-03-31 | $354.00K 10-Q · filed 2016-05-06 | $227.00K derived: sum of 2 quarters · filed 2017-03-09 | $219.00K derived: sum of 3 quarters · filed 2017-03-09 | -$231.00K derived: sum of 4 quarters · filed 2017-03-09 | |
| 2014-12-31 | -$127.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$135.00K derived: sum of 2 quarters · filed 2017-03-09 | -$585.00K derived: sum of 3 quarters · filed 2017-03-09 | -$164.00K 10-K · filed 2017-03-09 | |
| 2014-09-30 | -$8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$458.00K derived: sum of 2 quarters · filed 2015-11-06 | -$37.00K 10-Q · filed 2015-11-06 | -$64.00K derived: sum of 4 quarters · filed 2016-03-04 | |
| 2014-06-30 | -$450.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$29.00K 10-Q · filed 2015-08-07 | -$56.00K derived: sum of 3 quarters · filed 2016-03-04 | ||
| 2014-03-31 | $421.00K 10-Q · filed 2015-05-11 | $394.00K derived: sum of 2 quarters · filed 2016-03-04 | |||
| 2013-12-31 | -$27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-04 | $485.00K 10-K · filed 2016-03-04 | |||
| 2013-09-30 | $512.00K 10-Q · filed 2014-11-12 | ||||
| 2012-12-31 | $121.00K 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |